Citations

Clear

19 citation(s) found for "Shah, Ami J".

Newborn screening reduces survival disparities in SCID after stem cell transplant: A PIDTC report
Winestone, Lena E. , Logan, Brent R. , Liu, Xuerong , Williams, Olatundun , Dunn, Elizabeth A. , Thakar, Monica S. , Kidd, Sharon A. , Dorsey, Morna J. , O'Reilly, R, Kapoor, Neena , Kapadia, Malika , Jyonouchi, Soma , Chandra, Sharat , Chellapandian, Deepak , Chaudhury, Sonali , Chen, Karin , Rayes, Ahmad , Quigg, Troy C. , Teira, Pierre , Gillio, Alfred P. , Eissa, Hesham, Knutsen, Alan P., Aquino, Victor M. , Shereck, Evan , Lugt, Mark T. Vander , Rozmus, Jacob, Yu, Lolie C. , Shah, Ami J. , Joshi, Avni Y. , Buckley, Rebecca H. , Oved, Joseph H. , Azim, Hisham Abdel, Martinez, Caridad , Sullivan, Kathleen E. , Bleesing, Jack J., Madden, Lisa, Shenoy, Shalini , Seroogy, Christine M. , Rubin, Tamar N. , Licata, Jennifer, Andolina, Jeffrey R. , Burroughs, Lauri M. , Leiding, Jennifer W. , Marsh, Rebecca , Pai, Sung‐Yun , Torgerson, Troy R. , Heimall, Jennifer , Griffith, Linda M. , Puck, Jennifer M. , Dvorak, Christopher C. , Cowan, Morton J. , Liu, Xuerong , Mousallem, Talal , Dorsey, Morna J , O'Reilly, Richard J , Kapoor, Neena , Forbes Satter, Lisa R , Kapadia, Malika , Chandra, Sharat , Ebens, Christen L , Chellapandian, Deepakbabu , Chaudhury, Sonali , Chen, Karin , Dávila Saldaña, Blachy J , Rayes, Ahmad , Quigg, Troy C , Chandrakasan, Shanmuganathan , Bednarski, Jeffrey J , DeSantes, Kenneth B , Teira, Pierre , Gillio, Alfred P , Eissa, Hesham , Aquino, Victor M , Shereck, Evan B , Moore, Theodore Bruce , Caywood, Emi H , Vander Lugt, Mark T , Rozmus, Jacob , Broglie, Larisa A , Yu, Lolie C. , Shah, Ami J , Joshi, Avni Y , Buckley, Rebecca H , Dara, Jasmeen , Oved, Joseph H , Abdel Azim, Hisham , Martinez, Caridad , Prockop, Susan E , Sullivan, Kathleen E , Bleesing, Jack J , Keller, Michael D , Madden, Lisa M , Parikh, Suhag , Shenoy, Shalini , Seroogy, Christine M , Rubin, Tamar , Licata, Jennifer , Andolina, Jeffrey R , Kohn, Donald B , Burroughs, Lauri M , Leiding, Jennifer W , Marsh, Rebecca A , Notarangelo, Luigi D , Pai, Sung-Yun , Torgerson, Troy R , Pulsipher, Michael A. , Heimall, Jennifer , Cuvelier, Geoffrey D E , Griffith, Linda M , Puck, Jennifer M , Dvorak, Christopher C , Cowan, Morton J , Haddad, Elie , Winestone, Lena E , Satter, Lisa Forbes , Ebens, Christen L. , Saldaña, Blachy J. Dávila , Chandrakasan, Shanmuganathan , Knutsen, Alan P. , Broglie, Larisa , Dara, Jasmeen , Abdel‐Azim, Hisham , Prockop, Susan E. , Bleesing, Jack , Keller, Michael D. , Parikh, Suhag , Kohn, Donald B. , Cuvelier, Geoff D.E. , Haddad, Élie

Mayo Clinic

Journal of Human Immunity | July 7, 2026 | Volume: 2 | Issue: 5 | Pages: No page available

10.70962/jhi.20250231 | PMID 42416786 Get It

Black race and Hispanic ethnicity are associated with higher mortality in severe combined immunodeficiency (SCID) following hematopoietic cell transplantation (HCT), though mechanisms remain unclear. We evaluated 796 children with SCID who received nonsibling HCT between 1982 and 2020 using data from the Primary Immune Deficiency Treatment Consortium. Overall survival for Black (aHR 2.47, 95%CI 1.64, 3.71) and Asian/Pacific Islander patients (aHR 1.82, 95%CI 1.00, 3.30) was significantly lower compared with non-Hispanic White patients, while Hispanic patients had lower event-free survival (aHR 1.83, 95%CI 1.27, 2.63) compared with non-Hispanic White patients. Even after adjusting for age and infection, Black patients with SCID had more than twofold hazard of death compared with non-Hispanic White patients. NBS was associated with earlier diagnosis, reduced infection at HCT, and elimination of survival disparities between Black and non-Hispanic White patients. These findings suggest that universal, system-level interventions such as NBS can mitigate disparities in outcomes for children with SCID.
Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis
Romich, Ellen , Ogdie, Alexis, Stephens‐Shields, Alisa, Merkel, Peter A., Assassi, Shervin , Bujor, Andreea M. , Castelino, Flavia V. , Chung, Lorinda, Evnin, Luke, Gordon, Jessica , Griffith, Melissa, Hant, Faye N. , Harding, Monica, Lakin, Kimberly S., Lebiedz‐Odrobina, Dorota J., Luo, Yiming, McMahan, Zsuzsanna H. , Molitor, Jerry, Moore, Duncan F. , RIchardson, Carrie, Shah, Amit N., Steen, Virginia, Volkmann, Elizabeth R. , Zahn, Carleigh , Sandorfi, Nora , Investigators, for the CONQUER, Chung, Leland W.K. , Bujor, Andreea , Castelino, Flavia V , Frech, Tracy M , Gordon, Jessica K , Hummers, Laura K , Khanna, Dinesh , Mayes, Maureen D , McMahan, Zsuzsanna H , Paik, Julie J , Skaug, Brian , Volkmann, Elizabeth R , Zahn, Carleigh , Chung, Lorinda , Assassi, Shervin , Ogdie, Alexis , Stephens‐Shields, Alisa J. , Merkel, Peter A. , Bernstein, Elana J. , Frech, Tracy , Khanna, Dinesh , Lakin, Kimberly S. , Lebiedz‐Odrobina, Dorota, Makol, Ashima , Mayes, Maureen D. , Molitor, Jerry A., Paik, Julie J. , Richardson, Carrie , Skaug, Brian , Shah, Ami A. , Shah, Ankoor, Steen, Virginia , VanBuren, John M.

Mayo Clinic

Arthritis Care & Research | April 20, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/acr.80069 | PMID 42007807 Get It

Objective This study aims to identify factors associated with patient global assessment (PtGA) and physician global assessment (PhGA) and discordance between them in systemic sclerosis (SSc). Methods Data from adults with early SSc (<5 years) from the Collaborative National Quality and Efficacy Registry were included. PtGA and PhGA (0–10 scale), clinical evaluations, and patient‐reported outcomes (PROs) were collected every six months. Multivariable mixed‐effects linear regression identified factors associated with PtGA and PhGA using (1) clinical variables and (2) clinical variables plus PROs. Relative weight analysis (RWA) determined the relative importance of each variable. Discordance (≥2 points between PtGA and PhGA) was assessed using multinomial mixed‐effects logistic regression. Results Among 956 patients (83% women, 33% limited disease), mean PtGA and PhGA at enrollment were 4.2 (SD 2.6) and 3.4 (SD 2.0), respectively ( P < 0.001). RWA of clinical variables identified modified Rodnan skin score (mRSS) and New York Heart Association (NYHA) functional class as most influential for both global assessments. After including PROs, PtGA was most influenced by measures of pain, skin symptoms, and physical function. Discordance occurred in 53% of patients (35% PtGA worse, 18% PhGA worse). Worse PtGA was associated with higher overall pain and discomfort. Worse PhGA was associated with higher mRSS, worse NYHA class, higher pain interference, and lower diffusing capacity of the lung. Conclusion Discordance between PtGA and PhGA occurs commonly, highlighting the need for comprehensive symptom management and measurement of disease burden in this complex disease. In SSc, differences in PtGA and PhGA reflect dissimilar weighting of data elements.
Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report
Alexander, Jessie L. , Saldaña, Blachy J. Dávila , Brazauskas, Ruta , Dammalapati, Sravya Gethika, Griffith, Linda M. , Shah, Ami J. , Shimano, Kristin A. , Ochs, Hans D., Bleesing, Jack , Ebens, Christen L. , Kapadia, Malika, Bauchat, Andrea , Oved, Joseph H. , Eissa, Hesham, Lust, Hannah , Haines, Hilary , Rayes, Ahmad , Madden, Lisa, Shereck, Evan , Miller, Holly, Martinez, Caridad , Rozmus, Jacob, Yu, Lolie C. , Chellapandian, Deepak , Aquino, Victor M., Knutsen, Alan P. , Chong, Hey , Chopek, Ashley, Gillio, Alfred P. , Joshi, Avni Y. , Rangarajan, Hemalatha G. , Andolina, Jeffrey R. , Lugt, Mark T. Vander , Prockop, Susan E. , Shyr, David C. , Sullivan, Kathleen E. , Weinacht, Katja G. , Torgerson, Troy R. , Marsh, Rebecca , Dvorak, Christopher C. , Heimall, Jennifer , Leiding, Jennifer W. , Puck, Jennifer M. , Rawlings, David J. , Cowan, Morton J. , Petrović, Aleksandra , Pai, Sung‐Yun , Burroughs, Lauri M. , Dávila Saldaña, Blachy J , Oved, Joseph H , Lust, Hannah , Rayes, Ahmad , Forbes Satter, Lisa R , Bednarski, Jeffrey J , Chellapandian, Deepakbabu , Joshi, Avni, Rangarajan, Hemalatha G , Andolina, Jeffrey R , Prockop, Susan E , Parikh, Suhag , Torgerson, Troy R , Chan, Alice Y , Haddad, Elie , Pulsipher, Michael A. , Leiding, Jennifer W , Kohn, Donald B , Puck, Jennifer M , Notarangelo, Luigi D , Pai, Sung-Yun , Burroughs, Lauri M , Ebens, Christen L , Dvorak, Christopher C , Shimano, Kristin A , Shah, Ami J , Ochs, Hans D., Kapoor, Neena R. , Keller, Michael D. , Chandrakasan, Shanmuganathan , Talano, Julie‐An , Satter, Lisa Forbes , Moore, Theodore Bruce , DeSantes, Kenneth B , Parikh, Suhag , Haddad, Élie , Kohn, Donald B.

Mayo Clinic

Blood Advances | December 5, 2025 | Volume: 10 | Issue: 5 | Pages: 1783-1798

10.1182/bloodadvances.2025017662 | PMID 41346295 Get It

Abstract Wiskott-Aldrich syndrome (WAS), an X-linked disorder characterized by immunodeficiency, thrombocytopenia, autoimmunity, and malignancy, can be effectively treated with allogeneic hematopoietic cell transplantation (HCT). Older age at HCT and mismatched donors are known to affect overall survival (OS). However, the influence of specific clinical manifestations or WAS variant class on OS and factors associated with event-free survival (EFS) remain incompletely defined. We analyzed outcomes of 308 patients with WAS who underwent HCT at 37 institutions of the Primary Immune Deficiency Treatment Consortium from 1990 to 2018. With a median follow-up of 5.3 years, the 5-year OS and EFS were 87.2% and 79.7%, respectively. Age ≥5 years, donor type, and a pre-HCT history of severe infection had a negative impact on OS and EFS, whereas pre-HCT autoimmunity had no impact. Reduced-intensity regimens were associated with lower T-cell and myeloid donor chimerism, particularly when non–busulfan-based regimens were used. Low myeloid donor chimerism was associated with lower platelet counts. Mixed chimerism was not consistently associated with post-HCT autoimmunity. Patients with class I (exon 1-2 missense and intron 5 hot spot variants) and class II variants (all others) had similar pre-HCT clinical symptom severity and no difference in OS, EFS, or platelet recovery post-HCT. In conclusion, our study showed excellent long-term OS and EFS after HCT for WAS, highlighting the importance of early HCT, before the development of severe infections. We confirmed that HCT using busulfan-based conditioning was associated with improved donor chimerism and platelet recovery. This trial was registered at www.clinicaltrials.gov as NCT02064933.
Hand Swelling and Other Non–Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US Cohorts
Hanif, Iqtidar, Assassi, Shervin , Mayes, Maureen D. , McMahan, Zsuzsanna H. , Charles, Julio, VanBuren, John M. , Alvey, Jessica S. , Ghaffari, Kimia , Castelino, Flavia V. , Chung, Lorinda, Evnin, Luke, Gordon, Jessica , Hant, Faye N. , Khanna, Dinesh , Lakin, Kimberly S. , Lebiedz‐Odrobina, Dorota, Molitor, Jerry A., Moore, Duncan F. , Sandorfi, Nora , Shah, Ankoor R. , Shanmugam, Victoria K. , Steen, Virginia , Volkmann, Elizabeth R. , Zahn, Carleigh , Chung, Leland W.K. , Castelino, Flavia V , Frech, Tracy M , Gordon, Jessica K , Hummers, Laura K , Khanna, Dinesh , Shanmugam, Victoria K , Volkmann, Elizabeth R , Zahn, Carleigh , Skaug, Brian , Chung, Lorinda , Assassi, Shervin , Mayes, Maureen D , Zhang, Meng , Bernstein, Elana J. , Chung, Lorinda, Frech, Tracy , Luo, Yiming , Makol, Ashima , Richardson, Carrie , Shah, Ami A. , Shah, Ankoor, Skaug, Brian

Mayo Clinic

Arthritis & Rheumatology | May 19, 2025 | Volume: 77 | Issue: 11 | Pages: 1585-1595

10.1002/art.43237 | PMID 40386907 Get It

Objective Raynaud phenomenon (RP) is often the initial clinical manifestation of systemic sclerosis (SSc), but some patients develop other manifestations first. To help elucidate the diversity of SSc presentation in its early stages, we describe the initial clinical manifestations and antinuclear antibody (ANA) profiles of patients in two early SSc cohorts. Methods All patient data in the Genetics vs Environment in Scleroderma Outcomes Study (GENISOS) and Collaborative National Quality and Efficacy Registry (CONQUER) cohorts were reviewed. Both studies enrolled patients within five years of the first non‐RP symptom. Results In GENISOS and CONQUER, respectively, 194 (44.2%) of 439 and 292 (31.1%) of 938 patients had a non‐RP initial symptom, most commonly puffy fingers/hands. Black patients had a non‐RP symptom before RP more commonly than patients in other race and ethnicity categories. Non‐RP first patients were more likely than RP first patients to have diffuse cutaneous involvement and joint contractures at enrollment and had a higher prevalence of RNA polymerase III antibody positivity. Conclusion In two large US cohorts, >30% of patients began to manifest SSc with puffy fingers/hands or other symptoms, without the “warning sign” of RP as their initial symptom. These patients presented with more severe skin and musculoskeletal disease on average, highlighting the importance of early recognition. The most common autoantibody associated with this presentation was RNA polymerase III. These results should be considered in efforts to recognize SSc in its earliest stages. Puffy fingers/hands, even in the absence of RP, should prompt consideration of early SSc and testing for ANA and SSc‐associated autoantibodies, including RNA polymerase III.
Conjunctival Biopsy of a Patient With Mpox
Tran, Meagan , Gonzalez, Valeria , Patel, Dharmendra , Shusko, Alexander , McCullough, Ann E. , Shah, Ami, McCullough, Ann, Gonzalez, Valeria V , Shah, Ami A. , Patel, Dharmendra

Mayo Clinic

JAMA Ophthalmology | January 11, 2024 | Volume: 142 | Issue: 2 | Pages: 157

10.1001/jamaophthalmol.2023.5780 | PMID 38206632 Get It

This case report describes a conjunctival biopsy of a patient with mpox infection.
A Case of Sustained Viral Shedding of Mpox With Ocular Involvement Resulting in Vision Loss
Speiser, Lisa , Wonnaparhown, Alex , Blair, Janis E. , Patel, Dharmendra, McCullough, Ann E. , Nicolasora, Nelson, Khalsa, Ann, Orenstein, Robert , Vikram, Holenarasipur R. , Seville, Maria Teresa , Speiser, Lisa J , Wonnaparhown, Alex M, Blair, Janis, Shah, Ami, Vikram, Holenarasipur R. , Shah, Ami A. , Huang, Vivian

Mayo Clinic

Open Forum Infectious Diseases | December 15, 2023 | Volume: 11 | Issue: 1 | Pages: No page available

10.1093/ofid/ofad632 | PMID 38264094 Get It

Abstract Mpox, caused by infection with Monkeypox virus, usually presents as a mild, self-limited illness in immunocompetent persons that resolves within 2–4 weeks. Serious complications have been reported when mpox lesions involve vulnerable anatomic sites, such as the eye, and in those with substantial immunosuppression. We describe a patient with advanced human immunodeficiency virus infection and sustained viral shedding of mpox with ocular involvement, which resulted in vision loss.
Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension
Simpson, Catherine E. , Ambade, A.S., Harlan, Robert, Roux, Aurelie , Aja, Susan, Graham, David R. , Grünig, Gabriele , Aldred, Micheala A. , Comhair, Suzy , Griffiths, Megan , Erzurum, Serpil C. , Beck, Gerald J. , Hill, Nicholas S. , Mathai, Stephen C. , Damico, Rachel L. , Group, and the PVDOMICS Study, Aldred, Micheala A , Erzurum, Serpil C , Hill, Nicholas S , Hassoun, Paul M , Mathai, Stephen C , Simpson, Catherine E , Shah, Ami A. , Hummers, Laura K , Hemnes, Anna R. , Leopold, Jane A. , Horn, Evelyn M. , Rosenzweig, Erika B. , Barnard, John , Tang, W.H. Wilson , Rischard, Franz , Frantz, Robert P. , Hassoun, Paul M. , Group, and the PVDOMICS Study

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | October 3, 2023 | Volume: 325 | Issue: 5 | Pages: L617-L627

10.1152/ajplung.00177.2023 | PMID 37786941 Get It

Our study shows an early increase in kynurenine pathway metabolism in at-risk subjects with systemic sclerosis who develop pulmonary arterial hypertension (PAH). We show that kynurenine pathway upregulation precedes clinical diagnosis and that this metabolic shift is associated with increased disease severity and shorter survival times. We also show that gene expression of TDO2, an enzyme that generates kynurenine from tryptophan, rises with PAH development.